Effect of evacetrapib on cardiovascular outcomes in patients with high-risk cardiovascular disease.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of thoracic disease"
DOI: 10.21037/jtd.2017.06.106
Abstract: Reducing serum low-density lipoprotein (LDL) cholesterol by statins has been shown to reduce cardiovascular events and mortality in secondary and primary prevention trials (1-3). Further reduction of serum LDL cholesterol in patients after an acute… read more here.
Keywords: evacetrapib cardiovascular; disease effect; cardiovascular outcomes; disease ... See more keywords